Charles Hammond

Charles Hammond practices at UCSD Hillcrest Medical Center in San Diego, California.

Charles Hammond's NPI, 1033641816, was assigned on March 30, 2017. Charles Hammond graduated from Wayne State University School Of Medicine in 2017. Charles Hammond holds California license A169655.

Charles Hammond's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Charles Hammond's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Charles Hammond is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Charles Hammond practices. Vendor and product names are available with a free account.

Hospitalist is Charles Hammond's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Charles Hammond is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Charles Hammond's licenses on file in 2 states: California and Michigan.

Dmand AI lists acute respiratory failure, bone infection, gastrointestinal bleeding, lung disease: COPD, asthma or bronchitis, pancreatitis, pneumonia and respiratory infection, pulmonary embolism and sepsis among the conditions Charles Hammond treats.

CMS data shows 631 Medicare services from Charles Hammond across 5 procedure codes in 2024, for 196 Medicare patients. Medicare paid $46,028 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 196 Medicare patients who saw Charles Hammond in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Charles Hammond's median patient age at 60, with 48% women.

In 2024, Charles Hammond wrote 168 Medicare Part D claims for 59 patients. 83% of them were for generic drugs. CMS names the drug for 66 of them, across 4 drugs with 11 or more claims each, at $504 in total drug cost. In 2019, CMS named 147 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Charles Hammond for performance year 2024, reported as part of a group. Charles Hammond accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Charles Hammond, published from 2020 to 2023. The most frequent topics are Bacteria, Bioreactors and Microalgae. Charles Hammond's most frequent co-authors are George J. Alangaden, MD, Indira Brar, MD and Zachary Dean Demertzis, DO.

Charles Hammond graduated from Wayne State University School Of Medicine in 2017.

Charles Hammond is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.